BASI Financial Facts

Cost of service revenue: 3.02M
Diluted net income (loss) per share: -0.09
See Full Income Statement

Current portion of long-term debt: -1.57M
Total liabilities and shareholders' equity: 23.82M
See Full Balance Sheet

Bioanalytical Systems (BASI) Earnings

  |   Expand Research on BASI
Next EPS Date 2/12/16 *Est. EPS Growth Rate -350.0% *Last Qtr.
Average EPS % Beat Rate -125.0% Revenue Growth Rate -22.4% *Last Qtr.
Average % Move 1-Wk after EPS +8.9% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
12/17/15 Q415 -$0.09N/A N/A $4.98M$6.42M N/A Details
8/13/15 Q315 $0.16N/A N/A $6.15M$6.03M N/A Details
5/14/15 Q215 -$0.01N/A N/A $5.73M$5.92M N/A Details
2/12/15 Q115 $0.01N/A N/A $5.85M$6.22M N/A Details
12/22/14 Q414 -$0.02N/A N/A $6.42M$5.51M N/A Details
8/14/14 Q314 $0.02N/A N/A $6.03M$5.6M N/A Details
5/15/14 Q214 -$0.03N/A N/A $5.91M$5.16M N/A Details
2/13/14 Q114 $0.04N/A N/A $6.22M$5.8M N/A Details